Page 26 - Read Online
P. 26

Page 4 of 20                Horwell et al. Microbiome Res Rep 2025;4:1    https://dx.doi.org/10.20517/mrr.2024.32

               Perhaps a nuanced slant to this, with increasing experimental data behind it, would be that immunogenic
               microbial products (bacterial DNA fragments, and metabolites) from the mother’s commensal microbiota
               are able to cross the placental barrier, giving the opportunity to educate the foetal immune system and
               promote immune tolerance before birth [31-33] . With the rapid progress in ex-utero embryogenesis
               technology , it is conceivable that in the near future, an animal model will be able to categorically prove if
                        [34]
               these immunogenic microbial products have any demonstrable relevance to foetal immunogenic and
               microbiomic development. For now, the evidence is insufficient to move away from the orthodoxy of the
               sterile womb hypothesis.

               Birth
               The very first moment of life has direct implications for the newborn’s microbiome. Delivery by CS or
               vaginal delivery (VD) has been shown to result in divergent neonatal microbiomes. This is believed to be
               due to the direct contact of the neonate with the maternal vaginal and perineal microbiome, allowing direct
                                                                  [43]
               vertical transmission to occur. Although very few mechanistic studies have been performed, transmission to
               the neonatal colon is believed to be via the oral route, a process phrased as the “bacterial baptism of
               birth” [35,36] . An interesting physiological adaption arises during the third trimester that confers a survival
               benefit to the child. In response to increasing oestrogen and progesterone, the mother’s vaginal microbiome
               is altered, a decrease in alpha diversity occurs, and the abundance of Lactobacillus spp. increases [37,38] . These
               species produce lactic acid, decreasing vaginal pH and consequentially reducing acid-sensitive pathobionts
                                        [38]
               such as Group B Streptococcus , which carry a high rate of neonatal sepsis and mortality.
               This “bacterial baptism” during VD is inherently absent in CS; instead, other microbial environments
               appear to play a role and lead to divergent microbiomes in the newborn. Multiple large studies have
               demonstrated  that  VD  is  associated  with  increased  abundances  of  Bacteroidetes  (particularly
               Bacteroides fragilis), Bacillota (chiefly Lactobacillus spp.), and Actinomycetota (almost exclusively from the
               Bifidobacterium spp.), all of which are typically found in the vagina or recto-anal microbiomes. In contrast,
               CS  has  been  associated with  species  typically  found  on  maternal  skin  and  microbiomes  found  in  the
               hospital,  with  neonates  having an  increased  abundance  of  Bacillota  (notably  Staphylococcus
               spp.),  Firmicutes, Enterococcus, and Klebsiella [14,39-46] .


               An increasing number of epidemiological studies have demonstrated a correlation between CS and an
               increased risk for negative long-term infant health outcomes. These findings are diverse and not always
               consistent, but there are reported increases in risk for type 1 diabetes mellitus (T1DM) [47-49] , obesity [48,50] ,
                                                                              [55]
                                                             [54]
               asthma [51,52] , eczema , respiratory  tract  infections , coeliac  disease , IBD [56,57] , attention  deficit/
                                [53]
               hyperactivity disorder , and autism . A recent meta-analysis of the paediatric consequences of CS, with
                                  [58]
                                              [59]
               over two million subjects, demonstrated increased risks for childhood asthma [OR 1.23 (1.14, 1.33)], T1DM
               [OR 1.07 (0.90, 1.27)], and obesity [OR 1.35 (1.29, 1.41) ] . With more than 25% of births being CS in
               Europe and North America, the potential implications to long-term health are a significant public health
               concern [60,61] . However, it is still unclear what causes these phenomena. Several explanations have been
               proposed, from the lack of stress hormones during an elective CS to an absence of intraocular pressure
                                                                          [62]
               being suggested to alter the inflammatory response of the newborn . However, the leading hypothesis
               relates to the divergent microbiomes associated with these methods of delivery . The first 24 h of life
                                                                                     [63]
               have been shown to be a prime opportunity for bacterial colonisation of the colon, in that the pH of the
               stomach is relatively neutral thanks to the ingestion of amniotic fluid in utero . This has been shown to
                                                                                   [43]
               complement the vertical transmission during VD of Lactobacillus, Bifidobacterium, and Bacteroides. These
               have been shown to regulate the developing immune system, influence the concentration of natural killer
               (NK) cells, regulate the population of T-lymphocytes, increase the secretion of Immunoglobulin A (IgA)
               antibodies, and aid in the metabolism of human milk oligosaccharides (HMOs) [64-70] . Furthermore,
   21   22   23   24   25   26   27   28   29   30   31